{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:23:41Z","timestamp":1790900621901,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s13555-023-00973-5","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T05:01:46Z","timestamp":1689397306000},"page":"1873-1887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment Preferences in Young Adults with Moderate to Severe Psoriasis: A Qualitative Study from the Nordic Countries"],"prefix":"10.1007","volume":"13","author":[{"given":"Flora Nicol","family":"Balieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Catton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta W.","family":"Clar\u00e9us","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti","family":"Danielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Fierens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Koulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amra","family":"Osmanecevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Pasternack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"issue":"2","key":"973_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2340\/00015555-0770","volume":"90","author":"M Augustin","year":"2010","unstructured":"Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M. Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. Acta Derm Venereol. 2010;90(2):147\u201351.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"973_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"973_CR3","first-page":"18","volume":"99","author":"K Danielsen","year":"2019","unstructured":"Danielsen K, Duvetorp A, Iversen L, \u00d8stergaard M, Seifert O, Tveit KS, et al. Prevalence of psoriasis and psoriatic arthritis and patient perceptions of severity in Sweden, Norway and Denmark: Results from the Nordic Patient Survey of Psoriasis and Psoriatic Arthritis. Acta Derm Venereol. 2019;99(1):18\u201325.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"973_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2340\/00015555-1485","volume":"93","author":"G Ragnarson Tennvall","year":"2013","unstructured":"Ragnarson Tennvall G, Hjortsberg C, Bjarnason A, Gniadecki R, Heikkil\u00e4 H, Jemec GB, et al. Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries. Acta Derm Venereol. 2013;93(4):442\u20135.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"973_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2340\/00015555-3048","volume":"99","author":"MK Rasmussen","year":"2019","unstructured":"Rasmussen MK, Enger M, Dahlborn AK, Juvik S, Fagerhed L, Dodge R, et al. The importance of achieving clear or almost clear skin for patients: results from the Nordic countries of the global. Acta Derm Venereol. 2019;99(2):158\u201363.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"973_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/jdv.15252","volume":"33","author":"KS Tveit","year":"2019","unstructured":"Tveit KS, Duvetorp A, \u00d8stergaard M, Skov L, Danielsen K, Iversen L, et al. Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP). J Eur Acad Dermatol Venereol. 2019;33(2):340\u201354.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"973_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson T, Pettersson U. Severe psoriasis\u2013oral therapy with a new retinoid. Dermatologica. 1978;157(4):238\u201344.","journal-title":"Dermatologica"},{"issue":"5","key":"973_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.17219\/acem\/69804","volume":"26","author":"A Bo\u017cek","year":"2017","unstructured":"Bo\u017cek A, Reich A. The reliability of three psoriasis assessment tools: psoriasis area and severity index, body surface area and physician global assessment. Adv Clin Exp Med. 2017;26(5):851\u20136.","journal-title":"Adv Clin Exp Med"},{"issue":"2","key":"973_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s13555-020-00363-1","volume":"10","author":"B Jankowiak","year":"2020","unstructured":"Jankowiak B, Kowalewska B, Krajewska-Ku\u0142ak E, Khvorik DF. Stigmatization and quality of life in patients with psoriasis. Dermatol Ther (Heidelb). 2020;10(2):285\u201396.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"973_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.5114\/ada.2020.93242","volume":"37","author":"B Jankowiak","year":"2020","unstructured":"Jankowiak B, Kowalewska B, Krajewska-Ku\u0142ak E, Khvorik DF, Niczyporuk W. Relationship between self-esteem and stigmatization in psoriasis patients. Postepy Dermatol Alergol. 2020;37(4):597\u2013602.","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"973_CR11","first-page":"215","volume":"25","author":"Z Sojevi\u0107 Timotijevi\u0107","year":"2017","unstructured":"Sojevi\u0107 Timotijevi\u0107 Z, Majcan P, Trajkovi\u0107 G, Reli\u0107 M, Novakovi\u0107 T, Mirkovi\u0107 M, et al. The impact of changes in psoriasis area and severity index by body region on quality of life in patients with psoriasis. Acta Dermatovenerol Croat. 2017;25(3):215\u201322.","journal-title":"Acta Dermatovenerol Croat"},{"issue":"11","key":"973_CR12","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s11136-016-1321-7","volume":"25","author":"M Obradors","year":"2016","unstructured":"Obradors M, Blanch C, Comellas M, Figueras M, Lizan L. Health-related quality of life in patients with psoriasis: a systematic review of the European literature. Qual Life Res. 2016;25(11):2739\u201354.","journal-title":"Qual Life Res"},{"key":"973_CR13","doi-asserted-by":"crossref","unstructured":"Feldman SR, Malakouti M, Koo JY. Social impact of the burden of psoriasis: effects on patients and practice. Dermatol Online J. 2014;20(8):13030\/qt48r4w8h2.","DOI":"10.5070\/D3208023523"},{"issue":"3","key":"973_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2340\/00015555-2833","volume":"98","author":"JH Hesselvig","year":"2018","unstructured":"Hesselvig JH, Egeberg A, Loft ND, Zachariae C, Kofoed K, Skov L. Correlation between dermatology life quality index and psoriasis area and severity index in patients with psoriasis treated with ustekinumab. Acta Derm Venereol. 2018;98(3):335\u20139.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"973_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/bjd.18361","volume":"182","author":"JM Norlin","year":"2020","unstructured":"Norlin JM, Nilsson K, Persson U, Schmitt-Egenolf M. Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goals. Br J Dermatol. 2020;182(4):965\u201373.","journal-title":"Br J Dermatol"},{"issue":"5","key":"973_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13021","volume":"32","author":"G Pistone","year":"2019","unstructured":"Pistone G, Gurreri R, Tilotta G, Caruso P, Curiale S, Bongiorno MR. Timing of quality of life improvements in psoriatic patients treated with different systemic therapies. Dermatol Ther. 2019;32(5): e13021.","journal-title":"Dermatol Ther"},{"issue":"6","key":"973_CR17","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/bjd.16326","volume":"178","author":"H Randa","year":"2018","unstructured":"Randa H, Lomholt JJ, Skov L, Zachariae R. Health-related quality of life in adolescents with psoriasis: an interview-based study. Br J Dermatol. 2018;178(6):1404\u201311.","journal-title":"Br J Dermatol"},{"issue":"2","key":"973_CR18","first-page":"189","volume":"10","author":"K Raval","year":"2011","unstructured":"Raval K, Lofland JH, Waters H, Piech CT. Disease and treatment burden of psoriasis: examining the impact of biologics. J Drugs Dermatol. 2011;10(2):189\u201396.","journal-title":"J Drugs Dermatol"},{"key":"973_CR19","first-page":"281","volume":"35","author":"EADV","year":"2021","unstructured":"EADV. Euroguiderm guideline for the treatment of psoriasis vulgaris. Syst Treat. 2021;35:281\u2013317.","journal-title":"Syst Treat"},{"issue":"4","key":"973_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00403-018-1808-x","volume":"310","author":"AG Florek","year":"2018","unstructured":"Florek AG, Wang CJ, Armstrong AW. Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review. Arch Dermatol Res. 2018;310(4):271\u2013319.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"973_CR21","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jdv.15324","volume":"33","author":"JT Maul","year":"2019","unstructured":"Maul JT, Navarini AA, Sommer R, Anzengruber F, Sorbe C, Mrowietz U, et al. Gender and age significantly determine patient needs and treatment goals in psoriasis\u2014a lesson for practice. J Eur Acad Dermatol Venereol. 2019;33(4):700\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"973_CR22","first-page":"981","volume":"16","author":"P Wolf","year":"2018","unstructured":"Wolf P, Weger W, Legat F, Painsi C, Saxinger W, M\u00fcllegger R, et al. Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional survey. J Dtsch Dermatol Ges. 2018;16(8):981\u201390.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"973_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041108","volume":"11","author":"IJ de Vere Hunt","year":"2021","unstructured":"de Vere Hunt IJ, McNiven A, Roberts A, Parmar H, McPherson T. \u2019Not just a piece of skin in front of you\u2019-a qualitative exploration of the experiences of adolescents with eczema and psoriasis with healthcare professionals. BMJ Open. 2021;11(1): e041108.","journal-title":"BMJ Open"},{"issue":"12","key":"973_CR24","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1007\/s11136-022-03189-w","volume":"31","author":"AL Newi","year":"2022","unstructured":"Newi AL, Tsianakas A, von Martial S, Sommer R, Blome C. How important is subjective well-being for patients? A qualitative interview study of people with psoriasis. Qual Life Res. 2022;31(12):3355\u201363.","journal-title":"Qual Life Res"},{"issue":"4","key":"973_CR25","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893\u2013907.","journal-title":"Qual Quant"},{"issue":"6999","key":"973_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/bmj.311.6999.251","volume":"311","author":"N Britten","year":"1995","unstructured":"Britten N. Qualitative interviews in medical research. BMJ. 1995;311(6999):251\u20133.","journal-title":"BMJ"},{"issue":"4","key":"973_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1365-2929.2006.02418.x","volume":"40","author":"B Dicicco-Bloom","year":"2006","unstructured":"Dicicco-Bloom B, Crabtree BF. The qualitative research interview. Med Educ. 2006;40(4):314\u201321.","journal-title":"Med Educ"},{"issue":"3","key":"973_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40271-015-0149-5","volume":"9","author":"C Blome","year":"2016","unstructured":"Blome C, von Usslar K, Augustin M. Feasibility of using qualitative interviews to explore patients\u2019 treatment goals: experience from dermatology. Patient. 2016;9(3):261\u20139.","journal-title":"Patient"},{"key":"973_CR29","volume-title":"Qualitative data analysis: an expanded sourcebook","author":"MBHAM Miles","year":"1994","unstructured":"Miles MBHAM. Qualitative data analysis: an expanded sourcebook. Thousand Oaks: Sage Publications; 1994."},{"issue":"2","key":"973_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5195\/jmla.2022.1271","volume":"110","author":"K Dhakal","year":"2022","unstructured":"Dhakal K. NVivo. J Med Libr Assoc. 2022;110(2):270\u20132.","journal-title":"J Med Libr Assoc"},{"issue":"2","key":"973_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1468-3083.2011.04440.x","volume":"27","author":"ML Schaarschmidt","year":"2013","unstructured":"Schaarschmidt ML, Umar N, Schmieder A, Terris DD, Goebeler M, Goerdt S, et al. Patient preferences for psoriasis treatments: impact of treatment experience. J Eur Acad Dermatol Venereol. 2013;27(2):187\u201398.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"973_CR32","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.2147\/PPA.S117006","volume":"10","author":"I Belinch\u00f3n","year":"2016","unstructured":"Belinch\u00f3n I, Rivera R, Blanch C, Comellas M, Liz\u00e1n L. Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Prefer Adherence. 2016;10:2357\u201367.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"973_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/jdv.14007","volume":"31","author":"L Puig","year":"2017","unstructured":"Puig L, Thom H, Mollon P, Tian H, Ramakrishna GS. Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2017;31(2):213\u201320.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"973_CR34","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2340\/00015555-2834","volume":"98","author":"ML Schaarschmidt","year":"2018","unstructured":"Schaarschmidt ML, Herr R, Gutknecht M, Wroblewska K, Gerdes S, Sticherling M, et al. Patients\u2019 and physicians\u2019 preferences for systemic psoriasis treatments: a Nationwide Comparative Discrete Choice Experiment (PsoCompare). Acta Derm Venereol. 2018;98(2):200\u20135.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"973_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00403-015-1613-8","volume":"308","author":"C Blome","year":"2016","unstructured":"Blome C, Gosau R, Radtke MA, Reich K, Rustenbach SJ, Spehr C, et al. Patient-relevant treatment goals in psoriasis. Arch Dermatol Res. 2016;308(2):69\u201378.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"973_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s13555-019-00334-1","volume":"9","author":"J Gorelick","year":"2019","unstructured":"Gorelick J, Shrom D, Sikand K, Renda L, Burge R, Dworkin C, et al. Understanding treatment preferences in patients with moderate to severe plaque psoriasis in the USA: results from a Cross-Sectional Patient Survey. Dermatol Ther (Heidelb). 2019;9(4):785\u201397.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"12","key":"973_CR37","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1111\/jdv.13248","volume":"29","author":"R Strohal","year":"2015","unstructured":"Strohal R, Prinz JC, Girolomoni G, Nast A. A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus. J Eur Acad Dermatol Venereol. 2015;29(12):2390\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"973_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12592","volume":"31","author":"D Rigopoulos","year":"2018","unstructured":"Rigopoulos D, Ioannides D, Chaidemenos G, Kallidis P, Voultsidou A, Matekovits A, et al. Patient preference study for different characteristics of systemic psoriasis treatments (Protimisis). Dermatol Ther. 2018;31(3): e12592.","journal-title":"Dermatol Ther"},{"issue":"2","key":"973_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40273-013-0126-6","volume":"32","author":"A Torbica","year":"2014","unstructured":"Torbica A, Fattore G, Ayala F. Eliciting preferences to inform patient-centred policies: the case of psoriasis. Pharmacoeconomics. 2014;32(2):209\u201323.","journal-title":"Pharmacoeconomics"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00973-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-00973-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00973-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T09:17:17Z","timestamp":1690190237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-00973-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-00973-5","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}